Multimodality Imaging in Evaluation of Cardiovascular Complications in Patients With COVID-19: JACC Scientific Expert Panel.


Journal

Journal of the American College of Cardiology
ISSN: 1558-3597
Titre abrégé: J Am Coll Cardiol
Pays: United States
ID NLM: 8301365

Informations de publication

Date de publication:
15 09 2020
Historique:
received: 19 05 2020
revised: 25 06 2020
accepted: 29 06 2020
pubmed: 28 7 2020
medline: 22 9 2020
entrez: 26 7 2020
Statut: ppublish

Résumé

Standard evaluation and management of the patient with suspected or proven cardiovascular complications of coronavirus disease-2019 (COVID-19), the disease caused by severe acute respiratory syndrome related-coronavirus-2 (SARS-CoV-2), is challenging. Routine history, physical examination, laboratory testing, electrocardiography, and plain x-ray imaging may often suffice for such patients, but given overlap between COVID-19 and typical cardiovascular diagnoses such as heart failure and acute myocardial infarction, need frequently arises for advanced imaging techniques to assist in differential diagnosis and management. This document provides guidance in several common scenarios among patients with confirmed or suspected COVID-19 infection and possible cardiovascular involvement, including chest discomfort with electrocardiographic changes, acute hemodynamic instability, newly recognized left ventricular dysfunction, as well as imaging during the subacute/chronic phase of COVID-19. For each, the authors consider the role of biomarker testing to guide imaging decision-making, provide differential diagnostic considerations, and offer general suggestions regarding application of various advanced imaging techniques.

Identifiants

pubmed: 32710927
pii: S0735-1097(20)36039-3
doi: 10.1016/j.jacc.2020.06.080
pmc: PMC7375789
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1345-1357

Informations de copyright

Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Références

Circ Res. 2020 May 8;126(10):1443-1455
pubmed: 32252591
J Cardiovasc Magn Reson. 2008 Apr 30;10:19
pubmed: 18447954
J Am Coll Cardiol. 2017 Aug 8;70(6):776-803
pubmed: 28461007
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
J Nucl Cardiol. 2020 Jun;27(3):1022-1029
pubmed: 32415626
Eur Heart J. 2020 May 14;41(19):1861-1862
pubmed: 32267502
Thromb Res. 2020 Jul;191:145-147
pubmed: 32291094
J Cardiovasc Magn Reson. 2020 Apr 27;22(1):26
pubmed: 32340614
Circulation. 2016 Dec 6;134(23):e579-e646
pubmed: 27832612
J Med Virol. 2020 Jul;92(7):819-823
pubmed: 32232979
JAMA Cardiol. 2020 Jul 1;5(7):819-824
pubmed: 32219357
J Clin Invest. 2020 May 1;130(5):2620-2629
pubmed: 32217835
N Engl J Med. 2020 Jul 30;383(5):494-496
pubmed: 32492294
J Am Soc Echocardiogr. 2013 Jun;26(6):567-81
pubmed: 23711341
JAMA Cardiol. 2020 Jul 1;5(7):811-818
pubmed: 32219356
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Am Coll Cardiol. 2020 Sep 15;76(11):1375-1384
pubmed: 32330544
J Thromb Haemost. 2020 Jul;18(7):1743-1746
pubmed: 32320517
J Am Coll Cardiol. 2019 Oct 15;74(15):1966-2011
pubmed: 31526538
N Engl J Med. 2020 Jun 18;382(25):2478-2480
pubmed: 32302081
JAMA. 2020 Apr 28;323(16):1612-1614
pubmed: 32191259
Circulation. 2020 Feb 11;141(6):e69-e92
pubmed: 31902242
J Thromb Haemost. 2020 Jun;18(6):1324-1329
pubmed: 32306492
J Nucl Cardiol. 2018 Jun;25(3):785-794
pubmed: 27638745
Respir Res. 2020 Apr 15;21(1):83
pubmed: 32293449
J Am Coll Cardiol. 2014 Nov 4;64(18):1929-49
pubmed: 25077860
J Cardiovasc Comput Tomogr. 2020 Mar - Apr;14(2):101-104
pubmed: 32317235
JAMA Cardiol. 2020 Jul 1;5(7):802-810
pubmed: 32211816
BMJ. 2020 Mar 26;368:m1091
pubmed: 32217556
Clin Chem Lab Med. 2020 Jun 25;58(7):1021-1028
pubmed: 32286245
Lancet. 2020 May 9;395(10235):1516
pubmed: 32334650
J Am Coll Cardiol. 2018 Oct 2;72(14):e91-e220
pubmed: 29097296
Circulation. 2017 Oct 17;136(16):e232-e268
pubmed: 28923988
Eur Heart J. 2021 Jan 7;42(2):206
pubmed: 32176300
J Thromb Haemost. 2020 Aug;18(8):2058-2060
pubmed: 32324960
Am J Emerg Med. 2021 Jun;44:352-357
pubmed: 32331955
Prog Cardiovasc Dis. 2020 Jul - Aug;63(4):518-524
pubmed: 32305557
Eur Heart J. 2020 Jan 14;41(3):407-477
pubmed: 31504439
J Am Coll Cardiol. 2020 Feb 11;75(5):453-463
pubmed: 32029126
Eur J Heart Fail. 2020 May;22(5):911-915
pubmed: 32275347
Circ Heart Fail. 2013 Jul;6(4):676-84
pubmed: 23733916
Circulation. 2019 Apr 30;139(18):e891-e908
pubmed: 30913893
Eur Respir J. 2004 Sep;24(3):436-42
pubmed: 15358703
JAMA Cardiol. 2020 Jul 1;5(7):831-840
pubmed: 32219363
JACC Basic Transl Sci. 2020 Apr 10;5(5):518-536
pubmed: 32292848
J Am Soc Echocardiogr. 2020 Jun;33(6):648-653
pubmed: 32503700

Auteurs

Lawrence Rudski (L)

Jewish General Hospital, McGill University, Montreal, Quebec, Canada.

James L Januzzi (JL)

Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Vera H Rigolin (VH)

Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Erin A Bohula (EA)

Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Ron Blankstein (R)

Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Amit R Patel (AR)

University of Chicago, Chicago, Illinois.

Chiara Bucciarelli-Ducci (C)

Bristol Heart Institute, University of Bristol, Bristol, United Kingdom.

Esther Vorovich (E)

Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Monica Mukherjee (M)

Johns Hopkins University, Baltimore, Maryland.

Sunil V Rao (SV)

Duke University Health System, Durham, North Carolina.

Rob Beanlands (R)

Ottawa Heart Institute, Ottawa, Ontario, Canada.

Todd C Villines (TC)

University of Virginia Health System, Charlottesville, Virginia.

Marcelo F Di Carli (MF)

Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: mdicarli@bwh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH